Rain(2) | $58,000,000 | (Aug 29, 2025)
ALIGNMT AI | $6,500,000 | (Aug 29, 2025)
Matey AI | $7,500,000 | (Aug 29, 2025)
Certified by Founder
Lodge
HI-Bio
start up
United States
- South San Francisco, California
- 05/01/2024
- Series B
- $95,000,000
Human Immunology Biosciences (HI-Bio) is leading clinical immunology into its next chapter with therapies that target cellular drivers of disease. HI-Bio uses a precision medicine approach to deliver therapies for patients with the auto-immune, allergic and inflammatory diseases that can together be referred to as immune-mediated diseases (IMDs).
- Industry Biotechnology Research
- Website https://hibio.com/
- LinkedIn https://www.linkedin.com/company/hibio/about/
Ordinal | $1,000,000 | (Aug 29, 2025)
Cumin Co. | $1,500,000 | (Aug 29, 2025)
Nuyug | $285,129 | (Aug 29, 2025)
Maisa | $25,000,000 | (Aug 29, 2025)
Copper | $28,000,000 | (Aug 29, 2025)
PALMONAS | $6,269,923 | (Aug 29, 2025)
Sola(US) | $8,000,000 | (Aug 29, 2025)
Mantic | $4,000,000 | (Aug 29, 2025)
M0 | $40,000,000 | (Aug 29, 2025)